AmBisome is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Amphotericin B.
| Product ID | 0469-3051_5f3f2915-440e-4faa-9e4d-71efae2f50e8 | 
| NDC | 0469-3051 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | AmBisome | 
| Generic Name | Amphotericin B | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 1997-08-11 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA050740 | 
| Labeler Name | Astellas Pharma US, Inc. | 
| Substance Name | AMPHOTERICIN B | 
| Active Ingredient Strength | 50 mg/12.5mL | 
| Pharm Classes | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 1997-08-11 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA050740 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 1997-08-11 | 
| Ingredient | Strength | 
|---|---|
| AMPHOTERICIN B | 50 mg/12.5mL | 
| SPL SET ID: | f7be6506-4d20-401e-a0ff-02ad7c33158a | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0469-3051 | AmBisome | amphotericin B | 
| 39822-1055 | Amphotericin B | Amphotericin B | 
| 55150-365 | Amphotericin B | Amphotericin B | 
| 62756-233 | Amphotericin B | Amphotericin B | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  AMBISOME  88849383  not registered Live/Pending | Gilead Sciences, Inc. 2020-03-26 | 
|  AMBISOME  73814641  1598121 Live/Registered | VESTAR, INC. 1989-07-24 |